Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Blood Administration Sets

K-Number: K220558 · 2022-11-17

Decision Date2022-11-17
Product CodeBRZ
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

Blood Administration Sets is a medical device manufactured by Baxter Healthcare Corporation. It received FDA 510(k) clearance on 2022-11-17 under approval number K220558. The device is classified under product code BRZ. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Blood Administration Sets?

Blood Administration Sets is a medical device that received FDA 510(k) clearance on 2022-11-17. It is manufactured by Baxter Healthcare Corporation. The 510(k) number is K220558.

When was Blood Administration Sets approved by the FDA?

Blood Administration Sets received FDA 510(k) clearance on 2022-11-17, under approval number K220558.

What company makes Blood Administration Sets?

Blood Administration Sets is manufactured by Baxter Healthcare Corporation.

What is the FDA product code for Blood Administration Sets?

The FDA product code for Blood Administration Sets is BRZ.

Related Clinical Trials

Related PubMed Literature

Other Devices by Baxter Healthcare Corporation

View all 48 devices →

Related Devices (Code: BRZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.